Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Conversion, Compromise, and Conversation-Moving to a Sensible Middle When Addressing Implantable Cardioverter-Defibrillator Therapy-Reply.

Kramer DB, Buxton AE, Zimetbaum PJ.

JAMA Cardiol. 2019 Jul 31. doi: 10.1001/jamacardio.2019.2610. [Epub ahead of print] No abstract available.

PMID:
31365023
2.

Cardioversion on reduced-dose direct oral anticoagulants: Are we confident?

Leshem E, Tung P, Noseworthy P, Zimetbaum P.

Heart Rhythm. 2019 Jul 9. pii: S1547-5271(19)30637-X. doi: 10.1016/j.hrthm.2019.07.005. [Epub ahead of print] No abstract available.

PMID:
31299300
3.

Treatment of painful left bundle branch block syndrome with cardiac resynchronization therapy or right-ventricular pacing.

Sroubek J, Tugal D, Zimetbaum PJ, Shvilkin A, Buxton AE.

HeartRhythm Case Rep. 2019 Mar 26;5(6):321-324. doi: 10.1016/j.hrcr.2019.03.005. eCollection 2019 Jun. No abstract available.

4.

Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.

Asundi A, Stanislawski M, Mehta P, Baron AE, Mull HJ, Ho PM, Zimetbaum PJ, Gupta K, Branch-Elliman W.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):855-862. doi: 10.1017/ice.2019.127. Epub 2019 Jun 4.

PMID:
31159895
5.

Hemodynamic response to supraventricular tachycardia in a patient with hypertrophic cardiomyopathy.

Ebrille E, Contreras-Valdes FM, Zimetbaum PJ.

HeartRhythm Case Rep. 2018 Dec 23;5(4):191-195. doi: 10.1016/j.hrcr.2018.12.006. eCollection 2019 Apr. No abstract available.

6.

Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only-Time to Adapt.

Kramer DB, Buxton AE, Zimetbaum PJ.

JAMA Cardiol. 2019 May 1;4(5):401-402. doi: 10.1001/jamacardio.2019.0882. No abstract available.

PMID:
30994859
7.

A combined care model using early access to specialists off-hours to reduce cardiac admissions.

Gavin M, Landon B, Lu J, Ganjehei L, Ho K, Nathanson L, Ullman E, Grossman S, Zimetbaum P.

Intern Emerg Med. 2019 Mar 27. doi: 10.1007/s11739-019-02076-6. [Epub ahead of print]

PMID:
30919209
8.

Activation Mapping With Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar-Related Atrial Tachycardias.

Anter E, Duytschaever M, Shen C, Strisciuglio T, Leshem E, Contreras-Valdes FM, Waks JW, Zimetbaum PJ, Kumar K, Spector PS, Lee A, Gerstenfeld EP, Nakar E, Bar-Tal M, Buxton AE.

Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006536. doi: 10.1161/CIRCEP.118.006536.

PMID:
30354312
9.

Tricuspid Valve Dysfunction Caused by Right Ventricular Leads.

Ebrille E, Chang JD, Zimetbaum PJ.

Card Electrophysiol Clin. 2018 Sep;10(3):447-452. doi: 10.1016/j.ccep.2018.05.006. Epub 2018 Jul 20. Review.

PMID:
30172281
10.

Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.

Waks JW, Passman RS, Matos J, Reynolds M, Thosani A, Mela T, Pederson D, Glotzer TV, Zimetbaum P.

Heart Rhythm. 2018 Nov;15(11):1601-1607. doi: 10.1016/j.hrthm.2018.06.027. Epub 2018 Jul 6.

PMID:
29981863
11.

Neuromuscular Disorders and the Role of the Clinical Electrophysiologist.

Ismail H, Raynor E, Zimetbaum P.

JACC Clin Electrophysiol. 2017 Oct;3(10):1069-1079. doi: 10.1016/j.jacep.2017.04.023. Epub 2017 Sep 13. Review.

12.

Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea.

Anter E, Di Biase L, Contreras-Valdes FM, Gianni C, Mohanty S, Tschabrunn CM, Viles-Gonzalez JF, Leshem E, Buxton AE, Kulbak G, Halaby RN, Zimetbaum PJ, Waks JW, Thomas RJ, Natale A, Josephson ME.

Circ Arrhythm Electrophysiol. 2017 Nov;10(11). pii: e005407. doi: 10.1161/CIRCEP.117.005407.

13.

Cardiac involvement in the muscular dystrophies.

Silvestri NJ, Ismail H, Zimetbaum P, Raynor EM.

Muscle Nerve. 2018 May;57(5):707-715. doi: 10.1002/mus.26014. Epub 2017 Nov 28. Review.

PMID:
29130502
14.

Mark E Josephson: The Boston Years.

Zimetbaum P.

Arrhythm Electrophysiol Rev. 2017 Apr;6(1):21-22. doi: 10.15420/aer.2017.6.1:PP9.

15.

Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation.

Chang JD, Manning WJ, Ebrille E, Zimetbaum PJ.

J Am Coll Cardiol. 2017 May 9;69(18):2331-2341. doi: 10.1016/j.jacc.2017.02.055. Review.

16.

Cardiac Direct Access Unit: A novel effort to leverage access to cardiologists to reduce hospitalization admissions.

Gavin MC, Zimetbaum PJ, Tuttle M, Ullman EA, Grossman SA.

Am J Emerg Med. 2017 Jun;35(6):910-911. doi: 10.1016/j.ajem.2017.03.070. Epub 2017 Mar 27. No abstract available.

PMID:
28372847
17.

Atrial Fibrillation.

Zimetbaum P.

Ann Intern Med. 2017 Mar 7;166(5):ITC33-ITC48. doi: 10.7326/AITC201703070. Review. Erratum in: Ann Intern Med. 2017 Jun 20;166(12 ):920.

PMID:
28265666
18.

Cost Effectiveness of Implantable Cardiac Monitor-Guided Intermittent Anticoagulation for Atrial Fibrillation: An Analysis of the REACT.COM Pilot Study.

Steinhaus DA, Zimetbaum PJ, Passman RS, Leong-Sit P, Reynolds MR.

J Cardiovasc Electrophysiol. 2016 Nov;27(11):1304-1311. doi: 10.1111/jce.13090. Epub 2016 Oct 4.

19.

Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia.

Bui AH, Roujol S, Foppa M, Kissinger KV, Goddu B, Hauser TH, Zimetbaum PJ, Ngo LH, Manning WJ, Nezafat R, Delling FN.

Heart. 2017 Feb;103(3):204-209. doi: 10.1136/heartjnl-2016-309303. Epub 2016 Aug 11.

20.

Controversy Surrounding ROCKET-AF: A Call for Transparency, But Should We Be Changing Practice?

Matos JD, Zimetbaum PJ.

Arrhythm Electrophysiol Rev. 2016 May;5(1):12-3. doi: 10.15420/aer.2016.24.2. No abstract available.

21.

Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.

Waks JW, Zimetbaum P.

J Cardiovasc Pharmacol Ther. 2017 Jan;22(1):3-19. doi: 10.1177/1074248416651722. Epub 2016 Jul 8.

PMID:
27260643
22.

Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial.

Donnino MW, Andersen LW, Berg KM, Chase M, Sherwin R, Smithline H, Carney E, Ngo L, Patel PV, Liu X, Cutlip D, Zimetbaum P, Cocchi MN; Collaborating Authors from the Beth Israel Deaconess Medical Center’s Center for Resuscitation Science Research Group.

Crit Care. 2016 Apr 3;20:82. doi: 10.1186/s13054-016-1257-x.

23.
24.

Editorial Commentary: Hard questions for mobile technology in cardiology.

Kramer DB, Yeh RW, Zimetbaum PJ.

Trends Cardiovasc Med. 2016 May;26(4):387-8. doi: 10.1016/j.tcm.2016.01.005. Epub 2016 Feb 1. No abstract available.

25.

Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads.

Delling FN, Hassan ZK, Piatkowski G, Tsao CW, Rajabali A, Markson LJ, Zimetbaum PJ, Manning WJ, Chang JD, Mukamal KJ.

Am J Cardiol. 2016 Mar 15;117(6):988-92. doi: 10.1016/j.amjcard.2015.12.038. Epub 2016 Jan 6.

26.

Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.

Charytan DM, Foley R, McCullough PA, Rogers JD, Zimetbaum P, Herzog CA, Tumlin JA; MiD Investigators and Committees.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):721-34. doi: 10.2215/CJN.09350915. Epub 2016 Jan 13.

27.

Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study.

Passman R, Leong-Sit P, Andrei AC, Huskin A, Tomson TT, Bernstein R, Ellis E, Waks JW, Zimetbaum P.

J Cardiovasc Electrophysiol. 2016 Mar;27(3):264-70. doi: 10.1111/jce.12864. Epub 2015 Nov 23.

28.

In reply. QTc prolongation and delamanid: access and safety.

Furin J, Harausz E, Zimetbaum P, Cox H.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1262-3. doi: 10.5588/ijtld.15.0541-2. No abstract available.

PMID:
26459548
29.

Obstructive sleep apnea and atrial fibrillation progression. Another reason to wear continuous positive airway pressure?

Tung P, Zimetbaum P.

Am Heart J. 2015 May;169(5):595-6. doi: 10.1016/j.ahj.2015.02.001. Epub 2015 Feb 7. No abstract available.

PMID:
25965705
30.

Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy.

Steinhaus DA, Waks JW, Collins R, Kleckner K, Kramer DB, Zimetbaum PJ.

Am J Cardiol. 2015 Jul 1;116(1):85-7. doi: 10.1016/j.amjcard.2015.03.047. Epub 2015 Apr 8.

31.

Update in cardiology: evidence published in 2014.

Steinhaus DA, Zimetbaum PJ.

Ann Intern Med. 2015 May 5;162(9):W86-90. doi: 10.7326/M15-0272. No abstract available.

PMID:
25927336
32.

Persistent sinus node suppression caused by thrombotic occlusion of an arteriovenous fistula: A report of two cases.

Huang HD, Waks JW, Josephson ME, Zimetbaum P.

HeartRhythm Case Rep. 2015 Apr 20;1(4):190-192. doi: 10.1016/j.hrcr.2015.02.004. eCollection 2015 Jul. No abstract available.

33.

QTc prolongation and treatment of multidrug-resistant tuberculosis.

Harausz E, Cox H, Rich M, Mitnick CD, Zimetbaum P, Furin J.

Int J Tuberc Lung Dis. 2015 Apr;19(4):385-91. doi: 10.5588/ijtld.14.0335. Review.

PMID:
25859992
34.

Role of atrial fibrillation burden in assessing thromboembolic risk.

Zimetbaum P, Waks JW, Ellis ER, Glotzer TV, Passman RS.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1223-9. doi: 10.1161/CIRCEP.114.001356. Review. No abstract available.

PMID:
25516580
35.

Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages.

Anter E, Silverstein J, Tschabrunn CM, Shvilkin A, Haffajee CI, Zimetbaum PJ, Buxton AE, Josephson ME, Gelfand E, Manning WJ.

Heart Rhythm. 2014 Nov;11(11):1890-7. doi: 10.1016/j.hrthm.2014.07.015. Epub 2014 Jul 14.

PMID:
25034183
36.

Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR.

Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR.

Heart Rhythm. 2014 Feb;11(2):216-21.

37.

Ectopy and expectations: can we predict atrial fibrillation, and should we try?

Kramer DB, Zimetbaum PJ.

Ann Intern Med. 2013 Dec 3;159(11):787-8. doi: 10.7326/0003-4819-159-11-201312030-00014. No abstract available.

38.

Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.

Waks JW, Zimetbaum PJ.

Expert Rev Cardiovasc Ther. 2013 Nov;11(11):1461-71. doi: 10.1586/14779072.2013.849572. Epub 2013 Oct 23.

PMID:
24147516
39.

The importance of atrial fibrillation burden and the origin of device-tailored anticoagulation.

Zimetbaum P, Ellis ER, Waks JW, Passman RS.

Pacing Clin Electrophysiol. 2013 Nov;36(11):1319-24. doi: 10.1111/pace.12275. Epub 2013 Sep 17.

PMID:
24102204
40.

Antiarrhythmic drugs 2013: state of the art.

Kumar K, Zimetbaum PJ.

Curr Cardiol Rep. 2013 Oct;15(10):410. doi: 10.1007/s11886-013-0410-2. Review.

PMID:
24048630
41.

Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR.

Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL.

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):488-97. doi: 10.1161/CIRCOUTCOMES.111.000054. Epub 2013 Jun 11.

42.

Diagnostic utility of a novel leadless arrhythmia monitoring device.

Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, Xu X, Yang F, Heidenreich PA.

Am J Cardiol. 2013 Aug 15;112(4):520-4. doi: 10.1016/j.amjcard.2013.04.017. Epub 2013 May 11.

43.

Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation.

Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E.

J Am Coll Cardiol. 2013 Jul 23;62(4):300-5. doi: 10.1016/j.jacc.2013.03.052. Epub 2013 Apr 23.

44.

Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.

Rayatzadeh H, Tan A, Chan RH, Patel SJ, Hauser TH, Ngo L, Shaw JL, Hong SN, Zimetbaum P, Buxton AE, Josephson ME, Manning WJ, Nezafat R.

J Cardiovasc Magn Reson. 2013 Apr 10;15:31. doi: 10.1186/1532-429X-15-31.

45.

Volumetric left ventricular ejection fraction is superior to 2-dimensional echocardiography for risk stratification of patients for primary prevention implantable cardioverter-defibrillator implantation.

Rayatzadeh H, Patel SJ, Hauser TH, Ngo LL, Shaw JL, Tan A, Buxton AE, Zimetbaum P, Josephson ME, Appelbaum E, Manning WJ, Nezafat R.

Am J Cardiol. 2013 Apr 15;111(8):1175-9. doi: 10.1016/j.amjcard.2012.12.051. Epub 2013 Feb 1.

46.

Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study.

Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ.

Pacing Clin Electrophysiol. 2013 Mar;36(3):328-33. doi: 10.1111/pace.12053. Epub 2012 Dec 13.

47.

The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study.

Rosenberg MA, Patton KK, Sotoodehnia N, Karas MG, Kizer JR, Zimetbaum PJ, Chang JD, Siscovick D, Gottdiener JS, Kronmal RA, Heckbert SR, Mukamal KJ.

Eur Heart J. 2012 Nov;33(21):2709-17. doi: 10.1093/eurheartj/ehs301. Epub 2012 Sep 12.

48.

Using interprofessional education strategies to improve collaborative attitudes among infectious diseases and cardiology physician trainees.

Stead W, O'Halloran TD, Bernier M, Zimetbaum PJ, Irish J.

Med Teach. 2012;34(7):594-5. doi: 10.3109/0142159X.2012.675102. Epub 2012 Apr 10. No abstract available.

PMID:
22489981
49.

Time for a change--a new approach to ICD replacement.

Kramer DB, Buxton AE, Zimetbaum PJ.

N Engl J Med. 2012 Jan 26;366(4):291-3. doi: 10.1056/NEJMp1111467. No abstract available.

PMID:
22276818
50.

Antiarrhythmic drug therapy for atrial fibrillation.

Zimetbaum P.

Circulation. 2012 Jan 17;125(2):381-9. doi: 10.1161/CIRCULATIONAHA.111.019927. Review. No abstract available.

PMID:
22249528

Supplemental Content

Loading ...
Support Center